G. Saydam Et Al. , "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.," Hematology (Amsterdam, Netherlands) , pp.1-7, 2018
Saydam, G. Et Al. 2018. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.. Hematology (Amsterdam, Netherlands) , 1-7.
Saydam, G., Haznedaroglu, I., Kaynar, L., Yavuz, A., Ali, R., Guvenc, B., ... Akay, O.(2018). Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.. Hematology (Amsterdam, Netherlands) , 1-7.
Saydam, G Et Al. "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.," Hematology (Amsterdam, Netherlands) , 1-7, 2018
Saydam, G Et Al. "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.." Hematology (Amsterdam, Netherlands) , pp.1-7, 2018
Saydam, G. Et Al. (2018) . "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.." Hematology (Amsterdam, Netherlands) , pp.1-7.
@article{article, author={G Saydam Et Al. }, title={Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.}, journal={Hematology (Amsterdam, Netherlands)}, year=2018, pages={1-7} }